American Heart Association Scientific Sessions 2020

Blacks, Hispanics Had Higher Rates of Hospitalization, Mortality from COVID-19

According to new data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, Black and Hispanic patients accounted for more than half of hospitalizations...
High Dose Flu Shot More Effective in RA Patients 

High-Dose Influenza Vaccine Similar to Standard-Dose for All-Cause Death, Cardiopulmonary Events

High-dose inactivated influenza vaccine did not reduce all-cause death or hospitalization for cardiopulmonary causes compared with a standard-dose vaccine in patients with high-risk cardiovascular...
Rivaroxaban Plus Aspirin Lowers Vs. Aspirin Alone in Those With Prior PCI

Rivaroxaban Plus Aspirin Reduced Cardiac, Limb Events in PAD After LER

Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after lower extremity revascularization (LER), according to...
Doctor examing clip board

Rivaroxaban Monotherapy Safe for AF After Coronary Stenting

The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent on the duration of time from stenting, according...
Doctors with Clipboard

40% of Middle-Aged Swedes Had Silent CAD

Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having severe CAD, according...
Evolocumab Associated with Reduced Risk for Complex Revascularization

Rates of Thromboembolic Complications High in COVID-19+ ICU Patients

Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), major adverse cardiovascular events, and...
A mid adult male doctor sits at a table across from an unrecognizable patient. He holds up a prescription bottle as he explains the benefits and risks of a new medication.

Rivaroxaban Plus Aspirin Protects Against Venous, Arterial Thrombotic Events After LER

Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism (VTE) after lower extremity revascularization (LER). Low-dose rivaroxaban plus...

Recent Cardiology Headlines

Respiratory Fluoroquinolone May Increase the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis

Respiratory Fluoroquinolone May Increase the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis

Among patients on receiving hemodialysis (HD), treatment with fluoroquinolone may be linked with an augmented risk of sudden cardiac death (SCD) when compared to...

Venous Thromboembolism in Hospitalized COVID-19 Patients Treated in a Single Academic Center in Mexico:...

There exists an increasing prevalence of venous thromboembolism (VTE) among patients with COVID-19, which is concerning, as it contributes significantly to morbidity and mortality. Researchers...
Noncompliance to Apixaban for A-Fib Due to Many Factors

Noncompliance to Apixaban for AFib Due to Many Factors

Patients with atrial fibrillation (AFib) cite multiple reasons for nonadherence to direct-acting oral anticoagulant (DOAC) therapy, according to a study published online in the...
Peripheral Artery Disease: Common, and Here's How to Spot It

Peripheral Artery Disease: Common, and Here’s How to Spot It

If you're older and your legs ache, it could be nothing -- or it could be a sign of peripheral artery disease (PAD). Have you...